Hongbo Lv

532 citations
16 papers · 383 indexed · h-index 7
Topics
Cancer-related molecular mechanisms research (5 papers)Circular RNAs in diseases (4 papers)MicroRNA in disease regulation (3 papers)
Partner nations
ChinaHong Kong

In The Last Decade

Hongbo Lv

15 papers receiving 377 citations

Peers

Hongbo Lv
Comparison fields: 5 of 81
  • Surgery 222
  • Pulmonary and Respiratory Medicine 155
  • Molecular Biology 82
  • Genetics 60
  • Cancer Research 55
Replace Joseph S. Sirintrapun with:
Joseph S. Sirintrapun United States
Tsunehiro Nishi Japan
Jian Wan China
Silvija‐Pera Jerkic Germany
Konstantinos Papadimitriou Greece
Joon Chae Na South Korea
Kazunao Hayashi Japan
Christina Bales United States
Sho Sato Japan
LM Lin Taiwan
Hongbo Lv relative to Joseph S. Sirintrapun United States Joseph S. Sirintrapun's profile →
Citations per field
00.5×1.5×2.0×
Joseph S. Sirintrapun · 1×
Citations per year

Countries citing papers authored by Hongbo Lv

Since Specialization
Citations

This map shows the geographic impact of Hongbo Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Lv more than expected).

Fields of papers citing papers by Hongbo Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbo Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Lv. The network helps show where Hongbo Lv may publish in the future.

Co-authorship network of co-authors of Hongbo Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbo Lv. A scholar is included among the top collaborators of Hongbo Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbo Lv. Hongbo Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 3
5 2
6 6
7 25
8 1
9 4
10 22
11 175
12
Differential expression of miR-21 and miR-75 in esophageal carcinoma patients and its clinical implication.
25
13 20
14 69
15 28
16 1

About Hongbo Lv

Hongbo Lv is a scholar working on Cancer Research, Computer Science Applications and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 383 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Surgery (222 citations), Pulmonary and Respiratory Medicine (155 citations) and Cancer Research (55 citations). Hongbo Lv has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Wei Sun, Jiaming Qian, Qing Xia, Wei Zhao, Yumei Li, Qingwen Sun, P. Hu, Haihua Li, Wei Wu and Hong Yang. Their work appears in journals such as PLoS ONE, Life Sciences and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026